Abstract FRI0204 – Table 1

Baseline characteristics and current treatment of the cohort N=38 for the radiographic study.

Type of SpA
N(%)
AS 38 (100%)BASRIs baseline
Mean (DS)
BASRIt baseline
Mean (DS)
6.44 (2.91)
7.60 (3.96)
Current treatment
NSAIDs
N(%)
Daily treatment: 22 (57.9%)
Casual treatment: 13 (34.2%)
Response: 35 (92.1%)
Type:
- 18 COX-2 selective (51.4%)
- 7 Diclofenac (18.4%)
- 5 Indomethacin (13.2%)
- 5 Others(13.2%)
Time of evolution
Diagnosis-inclusion in the registry
Mean (DS) years
11 (7.1)Degree of sacroiliitis
Me (RI)
4
(3–4
Current treatment
N (%) cDMARDs
- Sulfasalazine 1 (2.7%)
- Methotrexate 1 (2.7%)
Sex
Male
Female
N(%)
34 (89.5)
4 (10.5)
Degree of cervical spine
Me (RI)
1
(0–2)
Current treatment
N(%) bDMARDs
10 (26.3%)
- 4 Golimumab (10.5%)
- 3 Etanercept (7.9%)
- 1 Adalimumab (2.6%)
- 1 Infliximab (2.6%)
- 1 Secukinumab (2.6%)
Age
Mean (DS) years
58.2 (7.9)Degree of hips
Me (RI)
1
(0–2)